Insider Buy/Sell Details for the Healthcare Sector — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1606)
ALX ONCOLOGY HOLDINGS INC (ALXO)
Pinto Shelly — SVP, FINANCE AND CAO
Shares
3,925
Price
$1.11
Total Value
$4.36K
Shares Held After
88,273
% of Holdings
4.3%
EKSO BIONICS HOLDINGS, INC. (EKSO)
Jones Jason C — Chief Operating Officer
Shares
1,320
Price
$9.25
Total Value
$12.21K
Shares Held After
25,621
% of Holdings
4.9%
Beta Bionics, Inc. (BBNX)
Mensinger Mike — Chief Product Officer
Shares
2,200
Price
$30.10
Total Value
$66.22K
Shares Held After
80,752
% of Holdings
2.7%
Sight Sciences, Inc. (SGHT)
Taylor Brenton — EVP, Operations & R&D
Shares
619
Price
$7.48
Total Value
$4.63K
Shares Held After
170,212
% of Holdings
0.4%
Alignment Healthcare, Inc. (ALHC)
Kim Hyong — Chief Medical Officer
Shares
16,506
Price
$21.35
Total Value
$352.36K
Shares Held After
333,133
% of Holdings
4.7%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
3,155
Price
$15.17
Total Value
$47.86K
Shares Held After
75,026
% of Holdings
4.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Nickson Philip — Chief Business & Legal Officer
Shares
3,155
Price
$15.17
Total Value
$47.86K
Shares Held After
60,845
% of Holdings
4.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
15,000
Price
$60.28
Total Value
$904.20K
Shares Held After
50,440
% of Holdings
22.9%
Altimmune, Inc. (ALT)
Sohn Catherine A. — Director
Shares
500
Price
$4.24
Total Value
$2.12K
Shares Held After
1,500
% of Holdings
33.3%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
3,155
Price
$15.17
Total Value
$47.86K
Shares Held After
67,845
% of Holdings
4.4%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
10,135
Price
$15.17
Total Value
$153.75K
Shares Held After
624,403
% of Holdings
1.6%
Monte Rosa Therapeutics, Inc. (GLUE)
Dunn Edmund — Principal Accounting Officer
Shares
1,039
Price
$15.17
Total Value
$15.76K
Shares Held After
22,693
% of Holdings
4.4%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
2,629
Price
$15.17
Total Value
$39.88K
Shares Held After
62,371
% of Holdings
4.0%
Zymeworks Inc. (ZYME)
Moore Paul Andrew — Chief Scientific Officer
Shares
10,821
Price
$25.10
Total Value
$271.57K
Shares Held After
40,391
% of Holdings
21.1%
Zymeworks Inc. (ZYME)
Moore Paul Andrew — Chief Scientific Officer
Shares
9,289
Price
$25.10
Total Value
$233.13K
Shares Held After
31,212
% of Holdings
22.9%
Zymeworks Inc. (ZYME)
Galbraith Kenneth — Director
Shares
31,686
Price
$25.10
Total Value
$795.22K
Shares Held After
193,266
% of Holdings
14.1%
Zymeworks Inc. (ZYME)
Galbraith Kenneth — Director
Shares
22,657
Price
$25.10
Total Value
$568.62K
Shares Held After
158,286
% of Holdings
12.5%
Zymeworks Inc. (ZYME)
Smith Jeffrey T L — EVP & Chief Medical Officer
Shares
10,538
Price
$25.10
Total Value
$264.47K
Shares Held After
18,352
% of Holdings
36.5%
Viking Therapeutics, Inc. (VKTX)
Lian Brian — Director
Shares
6,400
Price
$35.07
Total Value
$224.42K
Shares Held After
2,499,291
% of Holdings
0.3%
Viking Therapeutics, Inc. (VKTX)
Lian Brian — Director
Shares
41,276
Price
$34.22
Total Value
$1.41M
Shares Held After
2,505,691
% of Holdings
1.6%
Viking Therapeutics, Inc. (VKTX)
Lian Brian — Director
Shares
53,279
Price
$33.38
Total Value
$1.78M
Shares Held After
2,546,967
% of Holdings
2.0%
Viking Therapeutics, Inc. (VKTX)
Lian Brian — Director
Shares
132,454
Price
$32.29
Total Value
$4.28M
Shares Held After
2,600,246
% of Holdings
4.8%
Viking Therapeutics, Inc. (VKTX)
Mancini Marianna — Chief Operating Officer
Shares
1,600
Price
$35.07
Total Value
$56.12K
Shares Held After
409,190
% of Holdings
0.4%
Viking Therapeutics, Inc. (VKTX)
Mancini Marianna — Chief Operating Officer
Shares
10,500
Price
$34.22
Total Value
$359.30K
Shares Held After
410,790
% of Holdings
2.5%
Viking Therapeutics, Inc. (VKTX)
Mancini Marianna — Chief Operating Officer
Shares
13,600
Price
$33.37
Total Value
$453.88K
Shares Held After
421,290
% of Holdings
3.1%
Viking Therapeutics, Inc. (VKTX)
Mancini Marianna — Chief Operating Officer
Shares
31,961
Price
$32.29
Total Value
$1.03M
Shares Held After
434,890
% of Holdings
6.8%
Viking Therapeutics, Inc. (VKTX)
ZANTE GREG — Chief Financial Officer
Shares
1,500
Price
$32.09
Total Value
$48.13K
Shares Held After
189,891
% of Holdings
0.8%
Viking Therapeutics, Inc. (VKTX)
ZANTE GREG — Chief Financial Officer
Shares
10,300
Price
$34.24
Total Value
$352.63K
Shares Held After
191,371
% of Holdings
5.1%
Viking Therapeutics, Inc. (VKTX)
ZANTE GREG — Chief Financial Officer
Shares
13,900
Price
$33.38
Total Value
$464.02K
Shares Held After
201,671
% of Holdings
6.4%
Viking Therapeutics, Inc. (VKTX)
ZANTE GREG — Chief Financial Officer
Shares
31,961
Price
$32.30
Total Value
$1.03M
Shares Held After
215,571
% of Holdings
12.9%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
309
Price
$68.00
Total Value
$21.01K
Shares Held After
171,958
% of Holdings
0.2%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
437
Price
$65.97
Total Value
$28.83K
Shares Held After
172,267
% of Holdings
0.3%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
1,200
Price
$64.49
Total Value
$77.39K
Shares Held After
172,704
% of Holdings
0.7%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
12,711
Price
$63.95
Total Value
$812.87K
Shares Held After
173,904
% of Holdings
6.8%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
14,792
Price
$63.01
Total Value
$932.04K
Shares Held After
186,615
% of Holdings
7.3%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
6,090
Price
$62.28
Total Value
$379.29K
Shares Held After
201,407
% of Holdings
2.9%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
46
Price
$68.00
Total Value
$3.13K
Shares Held After
474,908
% of Holdings
0.0%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
2,336
Price
$64.04
Total Value
$149.60K
Shares Held After
474,954
% of Holdings
0.5%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
5,873
Price
$62.91
Total Value
$369.47K
Shares Held After
477,290
% of Holdings
1.2%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
900
Price
$62.25
Total Value
$56.02K
Shares Held After
483,163
% of Holdings
0.2%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
600
Price
$61.12
Total Value
$36.67K
Shares Held After
484,063
% of Holdings
0.1%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
313
Price
$68.00
Total Value
$21.28K
Shares Held After
484,663
% of Holdings
0.1%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
900
Price
$66.01
Total Value
$59.41K
Shares Held After
484,976
% of Holdings
0.2%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
2,700
Price
$64.44
Total Value
$173.99K
Shares Held After
485,876
% of Holdings
0.6%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
11,842
Price
$63.84
Total Value
$755.99K
Shares Held After
488,576
% of Holdings
2.4%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
13,451
Price
$62.96
Total Value
$846.87K
Shares Held After
500,418
% of Holdings
2.6%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
6,164
Price
$62.23
Total Value
$383.59K
Shares Held After
513,869
% of Holdings
1.2%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
O'Brien Patrick — COO
Shares
4,368
Price
$61.20
Total Value
$267.32K
Shares Held After
520,033
% of Holdings
0.8%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
754
Price
$99.48
Total Value
$75.01K
Shares Held After
2,277,500
% of Holdings
0.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
2,209
Price
$98.42
Total Value
$217.41K
Shares Held After
2,278,254
% of Holdings
0.1%
Showing 1251–1300 of 1606 transactions (page 26 of 33)